Cargando…
Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649826/ https://www.ncbi.nlm.nih.gov/pubmed/34596489 http://dx.doi.org/10.1177/10497323211040768 |
_version_ | 1784611080824160256 |
---|---|
author | Sthamann, Erin McMullen, Linda M. |
author_facet | Sthamann, Erin McMullen, Linda M. |
author_sort | Sthamann, Erin |
collection | PubMed |
description | Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of the chemical imbalance hypothesis, overprescribing, and the availability of equally or more effective nonmedication interventions for depression. In this article, we employ a discursive analysis to show how online commenters fashion a particular counter-argument to these critiques. Prominent in this counter-argument is that only “real” depression benefits from antidepressants, and that a “one-size-does-not-fit-all” understanding of these medications is needed. We argue that, while this nuanced counter-critique contains features that make it difficult to undermine, it simultaneously embeds many unanswered questions. |
format | Online Article Text |
id | pubmed-8649826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-86498262021-12-08 Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms Sthamann, Erin McMullen, Linda M. Qual Health Res Research Articles Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of the chemical imbalance hypothesis, overprescribing, and the availability of equally or more effective nonmedication interventions for depression. In this article, we employ a discursive analysis to show how online commenters fashion a particular counter-argument to these critiques. Prominent in this counter-argument is that only “real” depression benefits from antidepressants, and that a “one-size-does-not-fit-all” understanding of these medications is needed. We argue that, while this nuanced counter-critique contains features that make it difficult to undermine, it simultaneously embeds many unanswered questions. SAGE Publications 2021-10-01 2021-12 /pmc/articles/PMC8649826/ /pubmed/34596489 http://dx.doi.org/10.1177/10497323211040768 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Articles Sthamann, Erin McMullen, Linda M. Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title | Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title_full | Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title_fullStr | Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title_full_unstemmed | Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title_short | Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms |
title_sort | critiquing the critique: resisting commonplace criticisms of antidepressants in online platforms |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649826/ https://www.ncbi.nlm.nih.gov/pubmed/34596489 http://dx.doi.org/10.1177/10497323211040768 |
work_keys_str_mv | AT sthamannerin critiquingthecritiqueresistingcommonplacecriticismsofantidepressantsinonlineplatforms AT mcmullenlindam critiquingthecritiqueresistingcommonplacecriticismsofantidepressantsinonlineplatforms |